Henan Lihua Pharmaceutical Co., Ltd. is located in Middle of Huanghe Street, Anyang Hi-Tech Industry Development Zone, Henan, China. The company was established in 1994, and has two plants—east plant and west plant. East plant is an administrative office area, established in 2004, and the total area is about 29000 m2. West plant is the main product production area, established in 1994, located in Qilidian, North part of Antang Road, Longan District, Anyang, Henan, China, and the total area is about 64000 m2. In 2015, Henan Lihua Pharmaceutical Co. Ltd. became the wholly-owned subsidiary company of listed VTR Biotechnology Co., Ltd. (stock code: 300381). The company currently has more than 500 employees.
Henan Lihua Pharmaceutical Co., Ltd. is a National High-tech Enterprise integrating the research, development, production and sales of corticosteroid active pharmaceutical ingredients (APIs) and related intermediates, as well as an Anyang Innovative Leading Enterprise and an Custom AA management enterprise. The main products include Prednisolone, Prednisone, Cortisone and Betamethasone and their derivatives, about 6 series and more than 50 varieties. Henan Lihua has also developed an in-depth cooperation with the Chinese Academy of Sciences and developed a novel green solvent-ionic liquid product series which has broad industrial development prospects and is the leading of the world. The company takes great pride in the core values of “Customer First, Technology-based, Honesty and Pragmatic, Harmony and win-win”. All products are produced and managed in compliance with ICHQ7, cGMP and other international guidelines and standards. These products also meet the following pharmacopeia specifications: Ph. Eur., BP, USP, JP, IP and ChP. Our products are presently sold to almost 60 countries and regions in Europe, North and South America, Asia and Africa..
For more than 20 years, Henan Lihua pharmaceutical Co., Ltd. always adheres to the "quality determines value, the pursuit of perfection is our eternal theme" quality concept, our company has successively passed GMP inspection and re-inspection of National Food and Drug Administration, Henan Food and Drug Administration and Germany authority, passed the on-site inspection of USFDA, MFDS of Korea, EDQM and EU authorities (FIMEA), and obtained the attestation of EDQM inspection certificate and EU GMP certificate. Prednisolone, Prednisone, Prednisolone acetate, Prednisolone sodium phosphate obtained CEP certificates. Form41 certificate of Prednisolone, Prednisone, Hydrocortisone, Hydrocortisone acetate, Prednisolone acetate, Betamethasone, Hydrocortisone Sodium Succinate were issued by India authority DCGI.
Henan Lihua follows the management philosophy, which focuses on “Create Value, Achieve Customers, Reputation First, and Sustainable Management”. High attention is paid to R&D. In 2020, Henan Province Glucocorticoid API Engineering Technology Research Center was honored in Henan Lihua. At present, the company has platforms including Henan Provincial Enterprise Technology Center, Henan Province Glucocorticoid API Engineering Technology Research Center and Provincial and Municipal Steroid Hormone Drug Engineering Research Center, which show that Henan Lihua has strong technological innovation ability in glucocorticoid API and related fields and provides strong technical support for the company's sustainable development, strong technical support for further into the international market.
Henan Lihua Pharmaceutical Co., Ltd. undertake the corporate mission of “to be dedicated to corticosteroid substance research and application, meet with customers' demands with exceptional product and service, and constantly enhance human living quality”, has always been adhering to the management idea of "Management creates benefits, detail decides success", strengthen safety, environmental protection and development of the EHS management system, promote the enterprise harmonious and sustainable development.
Looking forward to the future, Henan Lihua Pharmaceutical Co., Ltd. is marching toward the corporate vision goal of "To be the world’s leader in the corticosteroid industry"! Strive hard and forge ahead.